These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30982745)

  • 21. Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis.
    Nagai Y; Popiel HA
    Curr Pharm Des; 2008; 14(30):3267-79. PubMed ID: 19075705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The crystal structure of the human nascent polypeptide-associated complex domain reveals a nucleic acid-binding region on the NACA subunit .
    Liu Y; Hu Y; Li X; Niu L; Teng M
    Biochemistry; 2010 Apr; 49(13):2890-6. PubMed ID: 20214399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SRCP1 Conveys Resistance to Polyglutamine Aggregation.
    Santarriaga S; Haver HN; Kanack AJ; Fikejs AS; Sison SL; Egner JM; Bostrom JR; Seminary ER; Hill RB; Link BA; Ebert AD; Scaglione KM
    Mol Cell; 2018 Jul; 71(2):216-228.e7. PubMed ID: 30029002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAC and Zuotin/Hsp70 chaperone systems coexist at the ribosome tunnel exit in vivo.
    Ziegelhoffer T; Verma AK; Delewski W; Schilke BA; Hill PM; Pitek M; Marszalek J; Craig EA
    Nucleic Acids Res; 2024 Apr; 52(6):3346-3357. PubMed ID: 38224454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.
    Meriin AB; Zhang X; He X; Newnam GP; Chernoff YO; Sherman MY
    J Cell Biol; 2002 Jun; 157(6):997-1004. PubMed ID: 12058016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structures of NAC domains of human nascent polypeptide-associated complex (NAC) and its αNAC subunit.
    Wang L; Zhang W; Wang L; Zhang XC; Li X; Rao Z
    Protein Cell; 2010 Apr; 1(4):406-416. PubMed ID: 21203952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular guardians for newborn proteins: ribosome-associated chaperones and their role in protein folding.
    Wegrzyn RD; Deuerling E
    Cell Mol Life Sci; 2005 Dec; 62(23):2727-38. PubMed ID: 16231086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
    Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
    J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the specificity of cotranslationally acting chaperones by systematic analysis of mRNAs associated with ribosome-nascent chain complexes.
    del Alamo M; Hogan DJ; Pechmann S; Albanese V; Brown PO; Frydman J
    PLoS Biol; 2011 Jul; 9(7):e1001100. PubMed ID: 21765803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion-Associated Toxicity is Rescued by Elimination of Cotranslational Chaperones.
    Keefer KM; True HL
    PLoS Genet; 2016 Nov; 12(11):e1006431. PubMed ID: 27828954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities.
    Hageman J; van Waarde MA; Zylicz A; Walerych D; Kampinga HH
    Biochem J; 2011 Apr; 435(1):127-42. PubMed ID: 21231916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of protein aggregation by chaperone modification of high molecular weight complexes.
    Labbadia J; Novoselov SS; Bett JS; Weiss A; Paganetti P; Bates GP; Cheetham ME
    Brain; 2012 Apr; 135(Pt 4):1180-96. PubMed ID: 22396390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteostasis of Huntingtin in Health and Disease.
    Koyuncu S; Fatima A; Gutierrez-Garcia R; Vilchez D
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage NAD+ biosynthetic pathway enzymes moonlight as molecular chaperones to protect against proteotoxicity.
    Pinkerton M; Ruetenik A; Bazylianska V; Nyvltova E; Barrientos A
    Hum Mol Genet; 2021 May; 30(8):672-686. PubMed ID: 33749726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases].
    Nagai Y
    Rinsho Shinkeigaku; 2009 Nov; 49(11):913-6. PubMed ID: 20030247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deactivation of TBP contributes to SCA17 pathogenesis.
    Hsu TC; Wang CK; Yang CY; Lee LC; Hsieh-Li HM; Ro LS; Chen CM; Lee-Chen GJ; Su MT
    Hum Mol Genet; 2014 Dec; 23(25):6878-93. PubMed ID: 25104854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical Nanomedicines for Polyglutamine-Based Neurodegenerative Diseases.
    Lee LKC; Leong LI; Liu Y; Luo M; Chan HYE; Choi CHJ
    Mol Pharm; 2021 Feb; 18(2):610-626. PubMed ID: 32584043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intrinsic ability of ribosomes to bind to endoplasmic reticulum membranes is regulated by signal recognition particle and nascent-polypeptide-associated complex.
    Lauring B; Kreibich G; Weidmann M
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9435-9. PubMed ID: 7568149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation.
    Seidel K; Siswanto S; Fredrich M; Bouzrou M; Brunt ER; van Leeuwen FW; Kampinga HH; Korf HW; Rüb U; den Dunnen WF
    Neuropathol Appl Neurobiol; 2016 Feb; 42(2):153-66. PubMed ID: 26095752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.